The Patent Finder

Progenra, Inc.

Also on record
Records under this name other than the patents Progenra, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 6 of 6 · Back to Progenra, Inc.

PatentTitleStatus Expires Confidence
US 9,382,574Di- and poly-ubiquitin deubiquitinase substrates and uses thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,680,139Anti-neoplastic compounds, compositions and methods
Lapsed on the fee record
Ended Mar 25, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 25, 2026From the USPTO record
US 11,273,154Azole compounds as ubiquitin-specific protease USP7 inhibitors
Lapsed on the fee record
Ended Mar 15, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 15, 2026From the USPTO record
US 8,518,660Di- and poly-ubiquitin deubiquitinase substrates and uses thereof
Formerly held
Lapsed on the fee record
Ended Aug 27, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 27, 2025From the USPTO record
US 9,717,717Methods of Treating Cancer Through the Inhibition of USP7 and Immune System Modulation
Formerly held
Lapsed on the fee record
Ended Aug 1, 2025 · High confidence
Lapsed on the fee recordEnded Aug 1, 2025High confidence
US 7,842,460Method for assessing proteolytic enzyme activity using ubiquitin fusion substrate
Lapsed on the fee record
Ended Nov 30, 2022 · From the USPTO record
Lapsed on the fee recordEnded Nov 30, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited